GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2l1 | multiple interactions | EXP | | 6480464 | CTD | [6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide co-treated with [Potassium Dichromate results in increased abundance of chromium hexavalent ion]] results in decreased expression of BCL2L1 protein; [Potassium Dichromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of BCL2L1 protein | PMID:35307491 | Bcl2l1 | decreases expression | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | chromium hexavalent ion results in decreased expression of BCL2L1 protein | PMID:16166740 | Bcl2l1 | increases expression | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | chromium hexavalent ion results in increased expression of BCL2L1 protein | PMID:25448439 PMID:29069462 | Bcl2l1 | multiple interactions | ISO | BCL2L1 (Homo sapiens) | 6480464 | CTD | Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2L1 protein]; TP53 protein affects the reaction [chromium hexavalent ion results in decreased expression of BCL2L1 protein] | PMID:16166740 PMID:25448439 | |
Go Back to source page | Continue to Ontology report |